skip to main content

News Archive

Date: 12/19/2023
University of Michigan Health Rogel Cancer Center were included on the 2023 list of Highly Cited Researchers. Published by Clarivate Analytics, the annual list highlights researchers who have demonstrated significant and broad influence in their area of research and who have authored multiple papers ranked in the top 1% by citations in their field.
Date: 12/06/2023
Daniel F. Hayes, M.D., received the Brinker Award for Clinical Research from Susan G. Komen, the world’s leading breast cancer organization. The award recognizes physician-scientists for their work to drive discoveries and improve breast cancer patient outcomes.
Date: 12/06/2023
Three Rogel Cancer Center researchers have received new grants from the American Cancer Society for projects focused on cervical cancer screening, genetic testing and glioblastoma. The grants, which include a Research Scholar Grant to Diane Harper and two postdoctoral fellow grants, total $1.16 million.
Date: 12/06/2023
With a new $3.4 million grant from the National Cancer Institute, a team of Rogel Cancer Center researchers will develop new tools to detect changes in precancerous lesions that are likely to become oral cancers. When detected early, this type of head and neck cancer can be curable.
Date: 12/01/2023
Researchers from the University of Michigan Health Rogel Cancer Center have developed a monitoring system using a research genetics program to trigger alerts about cancer patients suspected to have the DPYD gene variant.
Date: 11/29/2023
Rogel Cancer Center faculty and trainees will lead more than three dozen presentations, posters and moderated sessions at the American Society of Hematology 2023 annual meeting. This year’s meeting will be held in-person and virtually in San Diego, California. Find a list of U-M presenters and other resources for attendees.
Date: 11/29/2023
Everyone has a story. And those stories help show the different influences on each person’s life, helping to build empathy, challenge stereotypes and create a more inclusive environment. That’s the basis of a new DEI initiative the Rogel Oncology Clinical Trials Support Unit, or OCTSU, has started. DEI Storytelling gives a platform for team members to share their personal journey, anecdotes or reflections, with an emphasis on topics that may not be widely understood by all staff.
Date: 11/20/2023
For men with a type of low-risk early prostate cancer, surveillance can be an option over immediate treatment. To help providers and patients make more informed decisions about safely choosing surveillance, Rogel Cancer Center researcher Simpa Salami, M.D., M.P.H., received a $1.14 million grant from the National Cancer Institute to answer lingering questions about the biology of these early prostate cancers.
Date: 11/15/2023
Experts at the University of Michigan Health Rogel Cancer Center have found a potential solution for preventing a common and dangerous complication in patients that receive stem cell transplants from a donor’s blood or bone marrow.
Date: 11/09/2023
New research in the November 2023 issue of JNCCN—Journal of the National Comprehensive Cancer Network suggests that patients who have insufficient levels of vitamin D before starting paclitaxel treatment are more likely to experience peripheral neuropathy.